Send the following on WhatsApp
Continue to ChatComparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom - https://avesis.omu.edu.tr/yayin/f8a2ea68-a500-469b-ab6a-4704f981a96c/comparative-effectiveness-and-cost-effectiveness-of-natalizumab-and-fingolimod-in-rapidly-evolving-severe-relapsing-remitting-multiple-sclerosis-in-the-united-kingdom